Psoriasis

7 New Drugs for Rheumatology in 2018

July 30, 2018

Here’s a brief look at medications for rheumatologic disorders that were approved or granted a new indication in 2018.

Diet and Psoriatic Disease: 5 Questions Physicians Often Ask

July 12, 2018

New recommendations from the National Psoriasis Foundation offer answers. The express goal of these guidelines: to reduce disease severity through proper nutrition.

Hot Topics in Psoriatic Arthritis: Updates From EULAR 2018

July 09, 2018

Two recent studies focus on the risks of osteoporosis and cardiovascular disease in patients on the psoriatic arthritis/psoriasis spectrum.

Tendinopathy Afoot in Psoriasis Even without PsA

June 19, 2018

A diagnostic challenge: foot and ankle tendinopathy or enthesopathy in patients with psoriasis who do not have psoriatic arthritis.

Certolizumab Gets FDA Nod for Moderate to Severe Plaque Psoriasis in Adults

May 29, 2018

The approval makes Cimzia the first Fc-free, PEGylated anti-TNF treatment option for this indication.

Psoriasis: A Primary Care Primer

April 30, 2018

Most patients seen in primary care have mild to moderate plaque psoriasis, which is usually treatable with topical therapies.

Tildrakizumab Gets FDA Nod for Moderate to Severe Plaque Psoriasis

March 23, 2018

This novel interleukin-23 inhibitor targets psoriatic inflammation.

6 Top Rheumatology Apps for Patients

March 20, 2018

Help your patients help themselves. Take a look at 6 rheumatology apps you can discuss at the next visit.

Novel Biologics for Psoriasis

March 12, 2018

In late-breaking clinical trials, 3 novel biologic drugs show promise for the treatment of moderate to severe plaque psoriasis.

Topical Cannabis: Aye, There's the Rub

February 21, 2018

Another potential indication for medical marijuana: psoriasis.

x